Abstract
Preliminary studies also show that many of the fatalities of COVID-19 are due to over-activity of the immune system, and photobiomodulation (PBM) therapy mainly accelerates wound healing and reduces pain and inflammation. Therefore, this systematic review and meta-analysis was conducted to evaluate the probable effect of the PBM therapy on the lung inflammation or ARDS and accelerate the regeneration of the damaged tissue. We systematically searched major indexing databases, including PubMed/Medline, ISI web of science (WOS), Scopus, Embase, and Cochrane central, using standard terms without any language, study region, or type restrictions. Of the 438 studies found through initial searches, 13 met the inclusion criteria. After applying the exclusion criteria, the main properties of 13 articles on 384 animals included in this meta-analysis with a wide range of species include rat (n = 10) and rabbit (n = 3). The analysis revealed that PBM therapy reduced TNFα (SMD:-3.75, 95% CI: −4.49, −3.02, P < 0.00001, I2 = 10%), IL-1β (SMD:-4.65, 95% CI: −6.15, −3.16, P < 0.00001, I2 = 62%), and IL-6 (SMD:-4.20, 95% CI: −6.42, −1.97, P = 0.0002, I2 = 88%) significantly compared with the model controls. Hence, PBM therapy increased IL-10 significantly compared with the model controls (SMD:-4.65, 95% CI: −6.15, −3.16, P < 0.00001, I2 = 62%). PBM therapy also reduced MPO activity (SMD:-2.13, 95% CI: −3.38, −0.87, P = 0.0009, I2 = 64%) and vascular permeability (SMD:-2.59, 95% CI: −4.40, −0.77, P = 0.0052, I2 = 71%) in the lung using the Evans blue extravasation technique significantly compared with the model controls. This systematic review and meta-analysis revealed that the PBM therapy does utilize beneficial anti-inflammatory effect, modulation of the immune system, lung permeability, or bronchoalveolar lavage on lung damage in both animal models and clinical studies. However, animal model and clinical studies appear limited considering the quality of the included evidences; therefore, large clinical trials are still required.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Abbreviations
- ARDS :
-
Acute respiratory distress syndrome
- BALF :
-
Bronchoalveolar lavage fluid
- LLLT :
-
Low-level laser therapy
- MERS :
-
Middle East respiratory syndrome
- MOOSE :
-
Meta-analyses of Observational Studies in Epidemiology
- MPO :
-
Myeloperoxidase
- PBM :
-
Photobiomodulation
- PML :
-
Pulmonary microvascular leakage
- PRISMA :
-
Preferred Reporting Items for Systematic Reviews and Meta-analyses
- SARS :
-
Severe acute respiratory syndrome
- SARS-CoV-2 :
-
Severe acute respiratory syndrome coronavirus 2
- SD :
-
Standard deviation
- SMD :
-
Standardized mean difference
- WOS :
-
ISI web of science
References
Aimbire F, Albertine R, de Magalhães RG, Lopes-Martins RA, Castro-Faria-Neto HC, Zângaro RA, Chavantes MC, Pacheco MT (2005) Effect of LLLT Ga-Al-As (685 nm) on LPS-induced inflammation of the airway and lung in the rat. Lasers Med Sci 20(1):11–20. https://doi.org/10.1007/s10103-005-0339-9
Aimbire F, Albertini R, Pacheco MT, Castro-Faria-Neto HC, Leonardo PS, Iversen VV, Lopes-Martins RA, Bjordal JM (2006) Low-level laser therapy induces dose-dependent reduction of TNFalpha levels in acute inflammation. Photomed Laser Surg 24(1):33–37. https://doi.org/10.1089/pho.2006.24.33
Aimbire F, Ligeiro de Oliveira AP, Albertini R, Corrêa JC, Ladeira de Campos CB, Lyon JP, Silva JA Jr, Costa MS (2008) Low level laser therapy (LLLT) decreases pulmonary microvascular leakage, neutrophil influx and IL-1beta levels in airway and lung from rat subjected to LPS-induced inflammation. Inflammation 31(3):189–197. https://doi.org/10.1007/s10753-008-9064-4
Borczuk AC, Salvatore SP, Seshan SV, Patel SS, Bussel JB, Mostyka M, Elsoukkary S, He B, Del Vecchio C, Fortarezza F, Pezzuto F, Navalesi P, Crisanti A, Fowkes ME, Bryce CH, Calabrese F, Beasley MB (2020) COVID-19 pulmonary pathology: a multi-institutional autopsy cohort from Italy and New York City. Mod Pathol 33(11):2156–2168. https://doi.org/10.1038/s41379-020-00661-1
Burgos-Blasco B, Güemes-Villahoz N, Santiago JL, Fernandez-Vigo JI, Espino-Paisán L, Sarriá B, García-Feijoo J, Martinez-de-la-Casa JM (2020) Hypercytokinemia in COVID-19: tear cytokine profile in hospitalized COVID-19 patients. Exp Eye Res 200:108253–108253. https://doi.org/10.1016/j.exer.2020.108253
Cardoso LM, Pansani TN, Hebling J, de Souza Costa CA, Basso FG (2020) Photobiomodulation of inflammatory-cytokine-related effects in a 3-D culture model with gingival fibroblasts. Lasers Med Sci 35(5):1205–1212. https://doi.org/10.1007/s10103-020-02974-8
Cavalli G, Dagna L (2021) The right place for IL-1 inhibition in COVID-19. Lancet Respir Med 9(3):223–224. https://doi.org/10.1016/s2213-2600(21)00035-7
Chathappady House NN, Palissery S, Sebastian H (2021) Corona viruses: A review on SARS, MERS and COVID-19. Microbiol Insights 14:11786361211002481. https://doi.org/10.1177/11786361211002481
Costela-Ruiz VJ, Illescas-Montes R, Puerta-Puerta JM, Ruiz C, Melguizo-Rodríguez L (2020) SARS-CoV-2 infection: the role of cytokines in COVID-19 disease. Cytokine Growth Factor Rev 54:62–75. https://doi.org/10.1016/j.cytogfr.2020.06.001
da Cunha Moraes G, Vitoretti LB, de Brito AA, Alves CE, de Oliveira NCR, Dos Santos Dias A, Matos YST, Oliveira-Junior MC, Oliveira LVF, da Palma RK, Candeo LC, Lino-Dos-Santos-Franco A, Acrt H, Gimenes Júnior JA, Aimbire F, Vieira RP, Ligeiro-de-Oliveira AP (2018) Low-level laser therapy reduces lung inflammation in an experimental model of chronic obstructive pulmonary disease involving P2X7 receptor. Oxid Med Cell Longev 2018:6798238. https://doi.org/10.1155/2018/6798238
Danlos FX, Ackermann F, Rohmer J, Roumier M, Marabelle A, Michot JM (2021) High levels of TNFα in patients with COVID-19 refractory to tocilizumab. Eur J Cancer 149:102–104. https://doi.org/10.1016/j.ejca.2021.01.056
de Lima FM, Villaverde AB, Albertini R, de Oliveira AP, Faria Neto HC, Aimbire F (2010) Low-level laser therapy associated to N-acetylcysteine lowers macrophage inflammatory protein-2 (MIP-2) mRNA expression and generation of intracellular reactive oxygen species in alveolar macrophages. Photomed Laser Surg 28(6):763–771. https://doi.org/10.1089/pho.2009.2638
de Lima FM, Moreira LM, Villaverde AB, Albertini R, Castro-Faria-Neto HC, Aimbire F (2011a) Low-level laser therapy (LLLT) acts as cAMP-elevating agent in acute respiratory distress syndrome. Lasers Med Sci 26(3):389–400. https://doi.org/10.1007/s10103-010-0874-x
de Lima FM, Villaverde AB, Albertini R, Corrêa JC, Carvalho RL, Munin E, Araújo T, Silva JA, Aimbire F (2011b) Dual effect of low-level laser therapy (LLLT) on the acute lung inflammation induced by intestinal ischemia and reperfusion: action on anti- and pro-inflammatory cytokines. Lasers Surg Med 43(5):410–420. https://doi.org/10.1002/lsm.21053
de Lima FM, Albertini R, Dantas Y, Maia-Filho AL, Santana Cde L, Castro-Faria-Neto HC, França C, Villaverde AB, Aimbire F (2013a) Low-level laser therapy restores the oxidative stress balance in acute lung injury induced by gut ischemia and reperfusion. Photochem Photobiol 89(1):179–188. https://doi.org/10.1111/j.1751-1097.2012.01214.x
de Lima FM, Vitoretti L, Coelho F, Albertini R, Breithaupt-Faloppa AC, de Lima WT, Aimbire F (2013b) Suppressive effect of low-level laser therapy on tracheal hyperresponsiveness and lung inflammation in rat subjected to intestinal ischemia and reperfusion. Lasers Med Sci. 28(2):551–564. https://doi.org/10.1007/s10103-012-1088-1
de Lima FM, Aimbire F, Miranda H, Vieira RP, de Oliveira AP, Albertini R (2014) Low-level laser therapy attenuates the myeloperoxidase activity and inflammatory mediator generation in lung inflammation induced by gut ischemia and reperfusion: a dose-response study. J Lasers Med Sci 5(2):63–70
Dhar SK, Vishnupriyan K, Damodar S, Gujar S, Das M (2021) IL-6 and IL-10 as predictors of disease severity in COVID-19 patients: results from meta-analysis and regression. Heliyon 7(2):e06155. https://doi.org/10.1016/j.heliyon.2021.e06155
Fang WH, Yao YM, Shi ZG, Yu Y, Wu Y, Lu LR, Sheng ZY (2003) The mRNA expression patterns of tumor necrosis factor-alpha and TNFR-I in some vital organs after thermal injury. World J Gastroenterol 9(5):1038–1044. https://doi.org/10.3748/wjg.v9.i5.1038
Fazza TF, Pinheiro BV, da Fonseca LMC, Lpds S, Botelho MP, Lopes GM, de Paoli F, da Fonseca AS, Lucinda LMF, Reboredo MM (2020) Effect of low-level laser therapy on the inflammatory response in an experimental model of ventilator-induced lung injury. Photochem Photobiol Sci 19(10):1356–1363. https://doi.org/10.1039/d0pp00053a
Feldmann M, Maini RN, Woody JN, Holgate ST, Winter G, Rowland M, Richards D, Hussell T (2020) Trials of anti-tumour necrosis factor therapy for COVID-19 are urgently needed. Lancet 395(10234):1407–1409. https://doi.org/10.1016/S0140-6736(20)30858-8
Gibson PG, Qin L, Puah SH (2020) COVID-19 acute respiratory distress syndrome (ARDS): clinical features and differences from typical pre-COVID-19 ARDS. Med J Australia 213(2):54–56.e1. https://doi.org/10.5694/mja2.50674
Goldman JL, Sammani S, Kempf C, Saadat L, Letsiou E, Wang T, Moreno-Vinasco L, Rizzo AN, Fortman JD, Garcia JGN (2014) Pleiotropic effects of interleukin-6 in a “two-hit” murine model of acute respiratory distress syndrome. Pulm Circ 4(2):280–288. https://doi.org/10.1086/675991
Hamblin MR (2016) Photobiomodulation or low-level laser therapy. J Biophotonics 9(11–12):1122–1124. https://doi.org/10.1002/jbio.201670113
Hamblin MR, Agrawal T, de Sousa M (2016) Handbook of low-level laser therapy, 1st edn. Jenny Stanford Publishing, New York
Haybar H, Kazemnia K, Rahim F (2020) Underlying chronic disease and COVID-19 infection: A state-of-the-art review. Jundishapur J Chronic Dis Care 9(2):e103452. https://doi.org/10.5812/jjcdc.103452
Higgins JPT, Altman DG, Gøtzsche PC, Jüni P, Moher D, Oxman AD, Savović J, Schulz KF, Weeks L, Sterne JAC (2011) The Cochrane Collaboration’s tool for assessing risk of bias in randomised trials. BMJ 343:d5928. https://doi.org/10.1136/bmj.d5928
Iyer SS, Cheng G (2012) Role of interleukin 10 transcriptional regulation in inflammation and autoimmune disease. Crit Rev Immunol 32(1):23–63. https://doi.org/10.1615/critrevimmunol.v32.i1.30
Kany S, Vollrath JT, Relja B (2019) Cytokines in inflammatory disease. Int J Mol Sci 20(23):6008. https://doi.org/10.3390/ijms20236008
Lai C-C, Shih T-P, Ko W-C, Tang H-J, Hsueh P-R (2020) Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and coronavirus disease-2019 (COVID-19): the epidemic and the challenges. Int J Antimicrob Agents 55(3):105924–105924. https://doi.org/10.1016/j.ijantimicag.2020.105924
Leisman DE, Ronner L, Pinotti R, Taylor MD, Sinha P, Calfee CS, Hirayama AV, Mastroiani F, Turtle CJ, Harhay MO, Legrand M, Deutschman CS (2020) Cytokine elevation in severe and critical COVID-19: a rapid systematic review, meta-analysis, and comparison with other inflammatory syndromes. Lancet Respir Med 8(12):1233–1244. https://doi.org/10.1016/s2213-2600(20)30404-5
Liberati A, Altman DG, Tetzlaff J, Mulrow C, Gøtzsche PC, Ioannidis JP, Clarke M, Devereaux PJ, Kleijnen J, Moher D (2009) The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration. J Clin Epidemiol 62(10):e1–e34. https://doi.org/10.1016/j.jclinepi.2009.06.006
Meduri GU, Headley S, Kohler G, Stentz F, Tolley E, Umberger R, Leeper K (1995) Persistent elevation of inflammatory cytokines predicts a poor outcome in ARDS. Plasma IL-1 beta and IL-6 levels are consistent and efficient predictors of outcome over time. Chest 107(4):1062–1073. https://doi.org/10.1378/chest.107.4.1062
Merad M, Martin JC (2020) Pathological inflammation in patients with COVID-19: a key role for monocytes and macrophages. Nat Rev Immunol 20(6):355–362. https://doi.org/10.1038/s41577-020-0331-4
Miranda da Silva C, Peres Leal M, Brochetti RA, Braga T, Vitoretti LB, Saraiva Câmara NO, Damazo AS, Ligeiro-de-Oliveira AP, Chavantes MC, Lino-Dos-Santos-Franco A (2015) Low level laser therapy reduces the development of lung inflammation induced by formaldehyde exposure. PLoS One 10(11):e0142816. https://doi.org/10.1371/journal.pone.0142816
Nejatifard M, Asefi S, Jamali R, Hamblin MR, Fekrazad R (2021) Probable positive effects of the photobiomodulation as an adjunctive treatment in COVID-19: a systematic review. Cytokine 137:155312. https://doi.org/10.1016/j.cyto.2020.155312
Oliveira MC Jr, Greiffo FR, Rigonato-Oliveira NC, Custódio RW, Silva VR, Damaceno-Rodrigues NR, Almeida FM, Albertini R, Lopes-Martins RÁ, de Oliveira LV, de Carvalho Pde T, Ligeiro de Oliveira AP, Leal EC Jr, Vieira RP (2014) Low level laser therapy reduces acute lung inflammation in a model of pulmonary and extrapulmonary LPS-induced ARDS. J Photochem Photobiol B 134:57–63. https://doi.org/10.1016/j.jphotobiol.2014.03.021
Pacheco PAF, Faria RX (2021) The potential involvement of P2X7 receptor in COVID-19 pathogenesis: A new therapeutic target? Scand J Immunol 93(2):e12960. https://doi.org/10.1111/sji.12960
Pannone G, Caponio VCA, De Stefano IS, Ramunno MA, Meccariello M, Agostinone A, Pedicillo MC, Troiano G, Zhurakivska K, Cassano T, Bizzoca ME, Papagerakis S, Buonaguro FM, Advani S, Muzio LL (2021) Lung histopathological findings in COVID-19 disease – a systematic review. Infect Agents Cancer 16(1):34. https://doi.org/10.1186/s13027-021-00369-0
Pelletier-Aouizerate M, Zivic Y (2021) Early cases of acute infectious respiratory syndrome treated with photobiomodulation, diagnosis and intervention: two case reports. Clin Case Rep 9(4):2429–2437. https://doi.org/10.1002/ccr3.4058
Pinheiro MM, Fabbri A, Infante M (2021) Cytokine storm modulation in COVID-19: a proposed role for vitamin D and DPP-4 inhibitor combination therapy (VIDPP-4i). Immunotherapy 13(9):753–765. https://doi.org/10.2217/imt-2020-0349
Rabaan AA, Al-Ahmed SH, Muhammad J, Khan A, Sule AA, Tirupathi R, Al Mutair A, Alhumaid S, Al-Omari A, Dhawan M, Tiwari R, Sharun K, Mohapatra RK, Mitra S, Bilal M, Alyami SA, Emran TB, Moni MA, Dhama K (2021) Role of inflammatory cytokines in COVID-19 patients: A review on molecular mechanisms, immune functions, immunopathology and immunomodulatory drugs to counter cytokine storm. Vaccines 9(5):436
Ragab D, Eldin HS, Taeimah M, Khattab R, Salem R (2020) The COVID-19 cytokine storm; what we know so far. Front Immunol 11(1446). https://doi.org/10.3389/fimmu.2020.01446
Ramphul K, Ramphul Y, Park Y, Lohana P, Dhillon BK, Sombans S (2021) A comprehensive review and update on severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and coronavirus disease 2019 (COVID-19): what do we know now in 2021? Arch Med Sci Atheroscler Dis 6:e5–e13. https://doi.org/10.5114/amsad.2021.105065
Ranjbar K, Moghadami M, Mirahmadizadeh A, Fallahi MJ, Khaloo V, Shahriarirad R, Erfani A, Khodamoradi Z, Saadi MHG (2021) Methylprednisolone or dexamethasone, which one is superior corticosteroid in the treatment of hospitalized COVID-19 patients: a triple-blinded randomized controlled trial. BMC Infect Dis 21(1):337. https://doi.org/10.1186/s12879-021-06045-3
Rohatgi A (2021) WebPlotDigitizer. Available from: https://automeris.io/WebPlotDigitizer [cited 27 April 2021]
Rowaiye AB, Okpalefe OA, Onuh Adejoke O, Ogidigo JO, Hannah Oladipo O, Ogu AC, Oli AN, Olofinase S, Onyekwere O, Rabiu Abubakar A, Jahan D, Islam S, Dutta S, Haque M (2021) Attenuating the effects of novel COVID-19 (SARS-CoV-2) infection-induced cytokine storm and the implications. J Inflamm Res 14:1487–1510. https://doi.org/10.2147/jir.s301784
Saxena M, Ali D, Modi DR, Almarzoug MHA, Hussain SA, Manohrdas S (2020) Association of TNF-α gene expression and release in response to anti-diabetic drugs from human adipocytes in vitro. Diabetes Metab Syndr Obes 13:2633–2640. https://doi.org/10.2147/dmso.s265362
Schultze JL, Aschenbrenner AC (2021) COVID-19 and the human innate immune system. Cell 184(7):1671–1692. https://doi.org/10.1016/j.cell.2021.02.029
Sherafat J, Somayeh SM, Rostami-Nejad M, Razaghi Z, Tavirani MR, Razzaghi M (2020) The Effectiveness of Photobiomodulation Therapy (PBMT) in COVID-19 infection. J Lasers Med Sci 11(Suppl 1):S23–S29. https://doi.org/10.34172/jlms.2020.S4
Sigman SA, Mokmeli S, Monici M, Vetrici MA (2020a) A 57-year-old African American man with severe COVID-19 pneumonia who responded to supportive Photobiomodulation therapy (PBMT): first use of PBMT in COVID-19. Am J Case Rep 21:e926779. https://doi.org/10.12659/ajcr.926779
Sigman SA, Mokmeli S, Vetrici MA (2020b) Adjunct low level laser therapy (LLLT) in a morbidly obese patient with severe COVID-19 pneumonia: a case report. Can J Respir Ther 56:52–56. https://doi.org/10.29390/cjrt-2020-022
Stroup DF, Berlin JA, Morton SC, Olkin I, Williamson GD, Rennie D, Moher D, Becker BJ, Sipe TA, Thacker SB (2000) Meta-analysis of observational studies in epidemiology: a proposal for reporting. Meta-analysis of observational studies in epidemiology (MOOSE) group. JAMA 283(15):2008–2012. https://doi.org/10.1001/jama.283.15.2008
Tecchio C, Micheletti A, Cassatella MA (2014) Neutrophil-derived cytokines: facts beyond expression. Front Immunol 5:508–508. https://doi.org/10.3389/fimmu.2014.00508
Teixeira IS, Leal FS, Tateno RY, Palma LF, Campos L (2021) Photobiomodulation therapy and antimicrobial photodynamic therapy for orofacial lesions in patients with COVID-19: a case series. Photodiagnosis Photodyn Ther 34:102281. https://doi.org/10.1016/j.pdpdt.2021.102281
Vetrici MA, Mokmeli S, Bohm AR, Monici M, Sigman SA (2021) Evaluation of adjunctive Photobiomodulation (PBMT) for COVID-19 pneumonia via clinical status and pulmonary severity indices in a preliminary trial. J Inflamm Res 14:965–979. https://doi.org/10.2147/jir.s301625
Wan X, Wang W, Liu J, Tong T (2014) Estimating the sample mean and standard deviation from the sample size, median, range and/or interquartile range. BMC Med Res Methodol 14(1):135. https://doi.org/10.1186/1471-2288-14-135
Zhang Y, Zhong Y, Pan L, Dong J (2020) Treat 2019 novel coronavirus (COVID-19) with IL-6 inhibitor: are we already that far? Drug Discov Ther 14(2):100–102. https://doi.org/10.5582/ddt.2020.03006
Acknowledgments
This work was supported by the Air Pollution and Respiratory Diseases Research Center affiliated by Deputy of Research, Ahvaz Jundishapur University of Medical Sciences.
Ethical Consideration
This research was approved by the Ethics Committee of Ahvaz Jundishapur University of Medical Sciences.
Conflict of Interest
None.
Type
Systematic review and meta-analysis.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2021 Springer Nature Switzerland AG
About this chapter
Cite this chapter
Raji, H., Arjmand, B., Rahim, F. (2021). The Probable Protective Effect of Photobiomodulation on the Inflammation of the Airway and Lung in COVID-19 Treatment: A Preclinical and Clinical Meta-Analysis. In: Turksen, K. (eds) Cell Biology and Translational Medicine, Volume 15. Advances in Experimental Medicine and Biology(), vol 1376. Springer, Cham. https://doi.org/10.1007/5584_2021_665
Download citation
DOI: https://doi.org/10.1007/5584_2021_665
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-031-02377-4
Online ISBN: 978-3-031-02378-1
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)